Is a rebound around the corner for this fallen dividend champion?

Should you buy this fallen dividend champion on its turnaround prospects?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Education publisher Pearson (LSE: PSON) today announced that it is set to raise approximately $1bn from the sale of a 22% stake in Penguin Random House to its partner Bertelsmann.

News of the sale initially sent its shares up by more than 3% in early morning trading, as the company said that it intends to use £300m from the sale to buy back shares, with the remainder earmarked to bolster its balance sheet.

But its shares have since fallen back as investors weighed management’s comments on the firm’s new dividend policy, and by early afternoon, they were down by as much as 8%. As such, Pearson shares are on course for their biggest daily decline in three months.

Dividend cut

Although the company has yet to spell out its new dividend plan, management indicated that it would give more priority to its balance sheet and investment required to transform the business, in light of the current challenging market environment. Additionally, it would not use the income from its remaining 25% stake in Penguin to make future dividend calculations.

This marks an end to its progressive dividend policy, after 25 years of consecutive annual dividend increases.

Structural issues

The sale also does not change the structural issues affecting the group’s struggling education business in North America, but instead, increases its exposure to the under-performing division. As such, the publisher’s bottom line performance would become even more dependant on a recovery at its core business.

Unfortunately, Pearson’s lacklustre dividend plans indicate that a turnaround is far from imminent. City analysts seem to share that opinion, as they expect underlying earnings this year to fall by 17%. And with shares in the company trading at 14.1 times forward earnings this year, I don’t think there’s enough upside to play for.

Revenue miss

In other news today, household and personal care products company McBride (LSE: MCB) said it expects adjusted operating profit for the full year to be in line with previous expectations, despite challenging trading conditions in the second half.

Total group revenues, in constant currency terms, fell 5.9% from the prior year. The decline was mostly due to weaker demand, which caused underlying revenues to drop 3.8%, while McBride’s customer reduction project accounted for a further 2.1% of sales reduction.

Leaner cost base

Yet the firm continued to make steady progress on the cost saving front, and as a result of this, its leaner cost base was considered effective in mitigating the impact of competitive markets and raw material price inflation.

Encouragingly, McBride said in today’s update that management remains confident in the execution of its restructuring plan and is pleased with the progress to date. This confidence also seems to be shared by City analysts, as they expect underlying earnings-per-share to rise by 19% this year, with a further gain of 17% in 2018.

So in spite of today’s revenues miss, I reckon that fundamentals remain broadly intact. As such, I believe valuations are tempting, with shares in the company trading at just 12.1 times its expected earnings for next year.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Have a £20,000 lump sum? Here’s how to target a £8,667 yearly passive income

How to turn £20,000 into a £8,667 passive income? Our Foolish author explains one counterintuitive strategy to build such an…

Read more »

British coins and bank notes scattered on a surface
Dividend Shares

2 dividend stocks that yield double the current UK interest rate

Following the latest UK interest rate cut, Jon Smith points out a couple of options that offer generous income relative…

Read more »

Investing Articles

A 9% yield and now this! Check out the stunning Taylor Wimpey share price forecast for 2026

Harvey Jones has kept the faith in Taylor Wimpey shares despite a difficult run, bolstered by their incredible yield. Next…

Read more »

Investing Articles

How much do you need in an ISA to aim for a life-changing passive income of £30,000 a year?

Harvey Jones says ISA savers can transform their futures in 2026 by investing in FTSE 100 dividend stocks with huge…

Read more »

Investing Articles

My top 10 ISA and SIPP stocks in 2026

Find out why a FTSE 100 investment trust is now this writer's top holding across his Stocks and Shares ISA…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

£10,000 invested in Rolls-Royce shares 5 Christmases ago is now worth…

James Beard reflects on the post-pandemic Rolls-Royce share price rally and whether the group could become the UK’s most valuable…

Read more »

Investing Articles

Will Nvidia shares continue their epic run into 2026 and beyond?

Nvidia shares have an aura of invincibility as an AI boom continues to benefit the chipmaker. Can anything stop the…

Read more »